Come up with a name for your new list and we'll add to it:
Syndexa Pharmaceuticals raised a round of funding on October 28, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Syndexa Pharmaceuticals is dedicated to the discovery and development of drugs targeting biological mechanisms for the treatment and prevention of metabolic diseases including obesity, type 2 diabetes…